Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026248
Filing Date
2024-11-06
Accepted
2024-11-06 16:51:22
Documents
1
Period of Report
2024-11-04

Document Format Files

Seq Description Document Type Size
1 form4-11062024_091118.html 4  
1 form4-11062024_091118.xml 4 3561
  Complete submission text file 0001415889-24-026248.txt   5115
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL STAMFORD CT 06902
Business Address
Posner Christopher (Reporting) CIK: 0001748265 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 241431857